Hansa Biopharma AB(MX:HNSAN)
MX:HNSAN
Hansa Biopharma AB earnings date
Hansa Biopharma AB (HNSAN) Q2 2022 Earnings Report
0 Followers
MX:HNSAN Q2 2022 EPS Results
- Actual EPS
- -MXN 3.56
- Consensus EPS
- -MXN 34.88
- Beat/Miss
- Beat by +MXN 31.32
- One Year Ago EPS
- -MXN 5.56
MX:HNSAN Q2 2022 Revenue Results
- Actual Revenue
- MXN 49.23M
- Expected Revenue
- MXN 347.52M
- Beat/Miss
- Missed by -MXN 298.30M
- YoY Revenue Growth
- +482.05%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 07/19/2022
- Time
- Before Open
- Conference Call
- Tuesday, July 19, 2022
MX:HNSAN Upcoming Earnings
Hansa Biopharma AB's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:HNSAN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | -1.63- | -3.02 | ― | ― |
| Nov 11, 2026 | 2026 (Q3) | -2.64-3.26 | -3.26 | 0.00% (+0.00) | |
| Jul 22, 2026 | 2026 (Q2) | -0.63-4.77 | -4.72 | -1.19% (-0.06) | |
| Apr 23, 2026 | 2026 (Q1) | -2.70-3.60 | -1.03 | -250.91% (-2.57) | |
| Feb 11, 2026 | 2025 (Q4) | -2.94-3.02 | -7.61 | 60.29% (+4.59) | |
| Oct 30, 2025 | 2025 (Q3) | -3.24-3.26 | -2.85 | -14.38% (-0.41) | |
| Jul 17, 2025 | 2025 (Q2) | -3.10-4.72 | -6.15 | 23.33% (+1.44) | |
| Apr 24, 2025 | 2025 (Q1) | -4.98-1.03 | -7.74 | 86.75% (+6.71) | |
| Feb 06, 2025 | 2024 (Q4) | -3.69-7.61 | -4.48 | -70.00% (-3.13) | |
| Oct 17, 2024 | 2024 (Q3) | -4.51-2.85 | -8.91 | 67.99% (+6.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
